Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks Phantom! Patience is the answer. The motley cool dude doesn't even know that Baylor pays for all phase I trials and department of defense has paid for a lot of the Tpiv trials. We are not scattered and have not wasted our money. What an uninformed writer lol
The 1st read was only 2 people. it takes 3 months to get more read puts so they might only have only a handful of people read outs for Asco my may
Phantom., on conf call they had 30 individuals in the que. had doses like 13. Now the study says active not recruiting so I assume they have 45 in the que and will begin to dose the remaining individuals in the near future. I view this as real positive news!
My analysis as to why shorts will be burned shortly lol. Based on about a 6 million shares float (Phathom projection ), we have had significant shares gobbled up in large chunks of 20,000 shares at a time during the last few weeks. I remember one purchase of 196,000 purchased. I am assuming that these large blocks are by people that are not trading but are long term investors. With the shorts at 2.6 million shares short in they are increasing this game during the last 15 days they will be over 3 million shares short during the next reporting. With any good news about pancreatic cancer like their presentation being accepted for Asco then the shorts will be in trouble. Oh, pun attended in opening line.
Anybody what does a light green line mean for a trade? I know blue is a buy and red is a sell.
Up 1.98 per share pre market. Mr. Shorty in trouble!!! Lol
FYI a couple of shorts that have figured out that is time to cover and move on.
Shorts in world of hurt come Friday morning!! All we need is some positive updates late Thursday night!! lol start roasting those marshmallows...
This is like custards last stand for shorts. I bought more shares today. We shall see who is right. I am saying this stock is worth more than $250 million . It is as simple as that for there therapies. That is what I am banking on
FYI The shorts are in big trouble in covering MRKR now. With the pancreatic update and other positive news next week their attempts to pummel this stock is over. I can't figure out why they didn't cover at $4 in December and move on to another stock. They have increased their shorts to 2.4 million. I wouldn't doubt that number when reported on March 26th will have increased again to 2.7 million or so. Now they are going to have to cover at $7 and above. Oh well
Did someone really buy 249.60k shares at 2pm and not move the share price? That is what yahoo is showing
With the pancreatic statements the shorts game should be coming to an end! Lol
If I were short this stock I would be petrified if I read phantoms email. Thanks phantom!!
My guess is that the short interest will be up next timeframe too. At some point they have to cover lol
Short interest after bell today..
Well stated Phantom I second your appraisal!! Here , here!!
Keith, the market cap is around $250 million and this can go into the billions with a FDA approva for adjuvant AML .
Janney Montgomery Scottis the brokerage house
Mr. Shorty. Your game is over and you can't keep this price down. Now that Janney has informed their investors that this is a buy they have 10's of thousands of retail customers that will consider purchasing Marker .
I issued buy too! Who is Joann ? Sorry but I couldn't resist. Shorts are struggling to keep price down.
Mr. Shorty is going to get caught in a short squeeze ! Lol what happens in a month if vanguard increases their purchases another 500,000 shares and short interest goes up to 2,500,000??
Thanks Phathom, you put a lot of hard effort into that reply. But you give a clear picture where our float stands.
Phantom, at the merger you estimated the float at between 5 to 6 million shares. I went thru the 13f and totaled all the new brokerage funds and hedge funds that are new purchased around 5.3 million shares. Assuming that they are buy and how like our big hedge funds then the float is now down to 700,000 shares and that this stock is headed higher due to nobody selling their existing shares.
Not if it was me ! Lol
Lady I work at blue cross and we will love not just the cheaper cost of the therapy but that the patients will be treated not at a hospital but at a clinic. The cost savings are huge. There is only two authorized blue cross treatment centers now for Cart. Which is the mayo clinics in New York and Minnesota . The costs and complexity of treatment is just too high.
Shares are drying up at these low prices. We are headed higher. With Vanguard owing 995,000 shares are float is starting to diminish .
The awesome thing is we still are not paying for the pancreatic trial and breast cancer trial even thou we own the therapy! This company is awesome since we only have 7 employees and are with such a great institution that is a marker shareholder too .you got to love this setup!
Thanks FYI since I work for one of the Blues plans in the great USA I believe we will love the lower cost therapy that Marker has for AML and lymphoma. To be outpatient and no hospital stay is huge along with low cost. Cart cost to much just saying
Phantom, when are the next couple of trial updates? Thanks
I got scared before Tappimmune merged with Marker and panic sold my shares. Now that I actually own Marker I can't be shaken. A long term holder and the story only gets better with every release of trial data. As the picture gets clearer the shorts will have to cover
FYI Mr. Shorty cover at higher price. Wait for it!
I would be sweating bullets if I were short. Lol I love big New York crowds lol
Me. Shorty needs to worry based on crowd at today's conference . Lol
FYI 1,400 + attendees at CEO conference today. Mr. Kim will be getting the word out about marker today. We shall see if this moves the needle. Aisling and NEA are there too
Thanks are you sure Marker owns this? Looks like our 5 antigen therapy
Lloyd, what type of cancer is that study? Thsnks
It is on marker website under the February 20 to 24th presentation. 11 of 12 AML patients are in remission for median of 12 months. They will get approval for this treatment. The lymphoma data looks good too. Check out the presentations
Shorts need to worry now! Updated AML data is excellent
Burr, just be thankful you ain't (u like that) a Detroit lions fan! You got jobbed no doubt but we stink and have been jobbed many times by NFL. At least we both have Marker lol
I agree shorts can get burned bad and the new shorts don't make any sense with limited profit potential . Only want Viracyte merger of it is all in stock with revenue from them to be before marker so our dilution would be less this way. I have faith in our management team to do a good deal.